mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
2e-06 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
8e-06 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-05 |